NorthWest Biotherapeutics Inc (NWBO)

[maverick_1]

Longfellow ups the ante after 2 wks maintaining the pacesetter position with http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124786173 although Do_Due_Diligence has been narrowing that gap! I'd be remiss in not mentioning md1225 who is already on overdrive through other channels!

Backgrounder:
http://www.nwbio.com/dcvax-direct/

The likely 3 Direct COMBO's doing Ph2 for sarcoma and lung for which NWBO has been spending money to set up these trials per 8K's and last 10Q would appear to be:
1. BMY's Opdivo
2. Merck's Keytruda
3. Merck KGas as seen here AND not to be confused with #2:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=125001271

The others, that of lagging behind AZ who has been refocusing their oncology endeavors and Roche's Genentech likely to be still on the horizon: can lean and mean NWBO handle it?

In addition to the above, both Longfellow and Do-Due-Diligence have negated the following:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124771810

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124770718

supports this admission last week that NWBO as the biggest Bio Scam (which did NOT come as a surprise given my initial sense well over a year ago!): Why does he even bother to post? Hmmn.... only logic... paid as a basher.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=124953640